354 related articles for article (PubMed ID: 36746639)
1. Boosting Checkpoint Immunotherapy with Biomaterials.
Liu L; Pan Y; Zhao C; Huang P; Chen X; Rao L
ACS Nano; 2023 Feb; 17(4):3225-3258. PubMed ID: 36746639
[TBL] [Abstract][Full Text] [Related]
2. Advancing immune checkpoint blockade in colorectal cancer therapy with nanotechnology.
Liu Z; Xiang Y; Zheng Y; Kang X
Front Immunol; 2022; 13():1027124. PubMed ID: 36341334
[TBL] [Abstract][Full Text] [Related]
3. Biomaterial-based platforms for modulating immune components against cancer and cancer stem cells.
Desai N; Hasan U; K J; Mani R; Chauhan M; Basu SM; Giri J
Acta Biomater; 2023 Apr; 161():1-36. PubMed ID: 36907233
[TBL] [Abstract][Full Text] [Related]
4. Tailoring biomaterials for monitoring and evoking tertiary lymphoid structures.
Li H; Lin WP; Zhang ZN; Sun ZJ
Acta Biomater; 2023 Dec; 172():1-15. PubMed ID: 37739247
[TBL] [Abstract][Full Text] [Related]
5. Local and Targeted Delivery of Immune Checkpoint Blockade Therapeutics.
Han X; Li H; Zhou D; Chen Z; Gu Z
Acc Chem Res; 2020 Nov; 53(11):2521-2533. PubMed ID: 33073988
[TBL] [Abstract][Full Text] [Related]
6. Advanced Biomaterials with Intrinsic Immunomodulation Effects for Cancer Immunotherapy.
Chen W; Li C; Jiang X
Small Methods; 2023 May; 7(5):e2201404. PubMed ID: 36811240
[TBL] [Abstract][Full Text] [Related]
7. Advances in immunotherapy delivery from implantable and injectable biomaterials.
Leach DG; Young S; Hartgerink JD
Acta Biomater; 2019 Apr; 88():15-31. PubMed ID: 30771535
[TBL] [Abstract][Full Text] [Related]
8. Local biomaterials-assisted cancer immunotherapy to trigger systemic antitumor responses.
Chen Q; Chen M; Liu Z
Chem Soc Rev; 2019 Nov; 48(22):5506-5526. PubMed ID: 31589233
[TBL] [Abstract][Full Text] [Related]
9. The nexus of dynamic T cell states and immune checkpoint blockade therapy in the periphery and tumor microenvironment.
Luo H; Wang W; Mai J; Yin R; Cai X; Li Q
Front Immunol; 2023; 14():1267918. PubMed ID: 37881432
[TBL] [Abstract][Full Text] [Related]
10. Immunosuppressive adenosine-targeted biomaterials for emerging cancer immunotherapy.
Wei Q; Zhang L; Zhao N; Cheng Z; Xin H; Ding J
Front Immunol; 2022; 13():1012927. PubMed ID: 36389700
[TBL] [Abstract][Full Text] [Related]
11. Enhancing antitumor response by combining immune checkpoint inhibitors with chemotherapy in solid tumors.
Heinhuis KM; Ros W; Kok M; Steeghs N; Beijnen JH; Schellens JHM
Ann Oncol; 2019 Feb; 30(2):219-235. PubMed ID: 30608567
[TBL] [Abstract][Full Text] [Related]
12. The application of nanotechnology in immune checkpoint blockade for cancer treatment.
Deng H; Zhang Z
J Control Release; 2018 Nov; 290():28-45. PubMed ID: 30287266
[TBL] [Abstract][Full Text] [Related]
13. T cell-mediated targeted delivery of tadalafil regulates immunosuppression and polyamine metabolism to overcome immune checkpoint blockade resistance in hepatocellular carcinoma.
Wang X; Zhang Q; Zhou J; Xiao Z; Liu J; Deng S; Hong X; Huang W; Cai M; Guo Y; Huang J; Wang Y; Lin L; Zhu K
J Immunother Cancer; 2023 Feb; 11(2):. PubMed ID: 36813307
[TBL] [Abstract][Full Text] [Related]
14. Multifunctional Nano-Biomaterials for Cancer Therapy via Inducing Enhanced Immunogenic Cell Death.
Chen Q; Li C; Wang Q
Small Methods; 2023 May; 7(5):e2201457. PubMed ID: 36703555
[TBL] [Abstract][Full Text] [Related]
15. Harnessing epithelial-mesenchymal plasticity to boost cancer immunotherapy.
Gu Y; Zhang Z; Ten Dijke P
Cell Mol Immunol; 2023 Apr; 20(4):318-340. PubMed ID: 36823234
[TBL] [Abstract][Full Text] [Related]
16. Immune checkpoint-targeted drug conjugates: A promising tool for remodeling tumor immune microenvironment.
Choi J; Jang H; Choi J; Choi Y; Yang Y; Shim MK; Kim SH
J Control Release; 2023 Jul; 359():85-96. PubMed ID: 37230294
[TBL] [Abstract][Full Text] [Related]
17. Nano-sized drug delivery systems to potentiate the immune checkpoint blockade therapy.
Shim MK; Song SK; Jeon SI; Hwang KY; Kim K
Expert Opin Drug Deliv; 2022 Jun; 19(6):641-652. PubMed ID: 35603410
[TBL] [Abstract][Full Text] [Related]
18. Biomaterial-assisted photoimmunotherapy for cancer.
Chen M; Chen Q
Biomater Sci; 2020 Nov; 8(21):5846-5858. PubMed ID: 33016276
[TBL] [Abstract][Full Text] [Related]
19. Recent advances in tumor microenvironment-targeted nanomedicine delivery approaches to overcome limitations of immune checkpoint blockade-based immunotherapy.
Kim J; Hong J; Lee J; Fakhraei Lahiji S; Kim YH
J Control Release; 2021 Apr; 332():109-126. PubMed ID: 33571549
[TBL] [Abstract][Full Text] [Related]
20. Advanced Biomaterials for Cell-Specific Modulation and Restore of Cancer Immunotherapy.
Ruan S; Huang Y; He M; Gao H
Adv Sci (Weinh); 2022 May; 9(16):e2200027. PubMed ID: 35343112
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
